Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NAT2 Polymorphism”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Not applicableStudy completedNCT03665402
What this trial is testing

A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status

Who this might be right for
TuberculosisDrug-Induced Liver InjuryAdverse Drug Event
Seoul National University Hospital 16
Not applicableStudy completedNCT00459251
What this trial is testing

Pharmacogenetics Study in Taiwan's Ethnic Groups

Who this might be right for
Healthy
Mackay Memorial Hospital 350
Not applicableUnknownNCT02076685
What this trial is testing

NAT2 Genotyping in Re-challenge Protocol of INH Titration in Patients With Anti-TB Medications-induced Hepatitis

Who this might be right for
Hepatotoxicity
National Taiwan University Hospital 60
Post-approval studies (Phase 4)Looking for participantsNCT06484530
What this trial is testing

Gene-guided N-acetyl Cysteine for Prophylaxis of Anti-tuberculous Drug- Induced Hepatitis

Who this might be right for
Tuberculosis (TB)Isoniazid ToxicityRifampicin Toxicity+6 more
Mahidol University 116
Not applicableUnknownNCT05913271
What this trial is testing

Study on the Correlation Between NAT2(N-acetyltransferase2) Gene Polymorphism and CrCl(Creatine Clreance) and the Efficacy and Safety of Levosimendan in Patients With Severe Heart Failure

Who this might be right for
Heart FailureLevosimendanEfficacy+1 more
Yi Han 352
Post-approval studies (Phase 4)Study completedNCT00298870
What this trial is testing

Randomized Trial for Pharmacogenomics-based Tuberculosis Therapy (RT-PGTT)

Who this might be right for
Pulmonary Tuberculosis
Osaka University 172